Accurate Wealth Management’s Repligen RGEN Stock Holding History

Accurate Wealth Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2	Closed	-$337	–	1152
2022 Q4	$337	Buy	+2	New	+$363	﹤0.01%	1530

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Accurate Wealth Management's RGEN Position: Q1 2023 in Review

Accurate Wealth Management sold out of Repligen (RGEN) in Q1 2023, closing a stake of 2 shares — an estimated $337 sold.

Accurate Wealth Management first reported a position in RGEN in Q4 2022 and held it in 1 quarter. The position peaked at $337 in Q4 2022. 446 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

Accurate Wealth Management reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
Accurate Wealth Management sold 2 Repligen shares in Q1 2023, an estimated $337.
Accurate Wealth Management first reported a position in Repligen in Q4 2022 and held it in 1 quarter.
Accurate Wealth Management's Repligen position peaked at $337 in Q4 2022.
446 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on Accurate Wealth Management's 13F filing for Q1 2023, filed 13 Apr 2023.